Product Program year 2025 Source: CMS Open Payments

Cerianna

Drug Pharma Imaging Agents - Nuclear Imaging

NDC 72874-001-01

Open in the dashboard

General payments

$159,658

127 payments

Research payments

$80,247

12 payments

Through program year 2025, $159,658 in general payments and $80,247 in research payments were reported against Cerianna (Pharma Imaging Agents - Nuclear Imaging).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

5 rows
Year Kind Amount Payments
2025 General $67,915 47
2025 Research $40,647 9
2024 General $84,543 77
2024 Research $39,600 3
2023 General $7,200 3

Breakdown

Who paid General payments · program years 2023–2025
  1. Ge Healthcare $159,658 127 payments
Top recipients General payments · program year 2025
  1. Susan Cha Diagnostic Radiology · Walnut Creek, CA $14,090 21% · 14 payments
  2. Delphine Chen Diagnostic Radiology · Seattle, WA $12,960 19% · 5 payments
  3. Joanne Mortimer Medical Oncology · Duarte, CA $11,742 17% · 9 payments
  4. Gary Ulaner Diagnostic Radiology · Los Angeles, CA $7,243 11% · 6 payments
  5. Hannah Linden Medical Oncology · Seattle, WA $6,875 10% · 4 payments

The top 5 of 9 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Diagnostic Radiology Radiology $39,266 60% · 4 practitioners
  2. Medical Oncology Internal Medicine $18,617 28% · 2 practitioners
  3. Hematology & Oncology Internal Medicine $4,358 7% · 1 practitioner
  4. Nuclear Medicine $3,174 5% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2025
  1. California $36,249 53% · 4 recipients
  2. Washington $19,835 29% · 2 recipients
  3. Arizona $4,973 7% · 1 recipient
  4. New York $4,358 6% · 1 recipient
  5. Texas $2,500 4% · 1 recipient

Each share is of general payments naming this product in 2025 where a state was reported.

127 general · 12 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record